Full-Time

Territory Manager

Confirmed live in the last 24 hours

Ceribell

Ceribell

201-500 employees

EEG devices for monitoring brain activity

Healthcare

Compensation Overview

$115k - $250kAnnually

+ Equity

Senior

Kansas City, MO, USA

Category
Field Sales
Sales & Account Management
Required Skills
Cold Calling

You match the following Ceribell's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Minimum of 5+ years of medical device sales experience, preferably with a background in selling disruptive technologies into hospitals.
  • Prior experience in Operating Room, Cath Lab, Critical Care, Neuro, Emergency Department, or Point of Care environments preferred.
  • Proven ability to manage a complex, hospital-based sales cycle effectively.
  • Demonstrated success with Return on Investment (ROI), Presidents Club (P-Club), and high sales rankings at current and former employers.
  • Demonstrates a hunter mentality with the ability to drive change through multiple stakeholders.
  • High EQ, unselfish, and can demonstrate prior roles where coaching was received and applied effectively.
Responsibilities
  • Close business to meet and exceed monthly, quarterly, and annual sales goals, playing a key role in helping Ceribell achieve its growth objectives.
  • Clearly communicate Ceribell’s value proposition to unlock new partnership opportunities and develop long-term relationships with key decision-makers within your territory.
  • Collaborate with Leadership and Account Managers to develop and grow a strong pipeline of new business and launch partnerships that deliver continued business growth.
  • Build and coach clinical champions within hospital departments, demonstrating success in advancing sales opportunities.
  • Call on multiple departments within hospitals, leveraging experience with various specialties to drive sales.
  • Successfully sell into the C-Suite and negotiate contracts with key decision-makers in hospitals.
  • Conduct effective discovery sessions with clinical and executive targets within health systems to understand their needs and tailor solutions accordingly.
  • Utilize cold calling skills to engage potential clients in the hospital setting, not limited to clinics or physician offices.
  • Demonstrate the ability to receive and implement feedback, showing examples of prior roles where coaching was successfully integrated.
  • Ensure compliance with applicable laws, regulations, and Ceribell policies.
Desired Qualifications
  • Ability to initiate and manage tasks independently while maintaining focus on sales targets.
  • Strong ability to build and maintain relationships across various hospital departments and specialties.
  • Proven success in negotiating complex contracts with senior hospital executives.
  • Ability to adapt to feedback and continuously improve performance through coaching.

Ceribell focuses on developing medical devices that utilize electroencephalogram (EEG) technology to monitor brain activity. Their main product, the Ceribell EEG Headband and Recorder, is designed for use by trained healthcare providers in professional settings. These devices help gather important data about a patient's brain activity, which healthcare professionals can analyze to make informed treatment decisions. Unlike some other EEG devices, Ceribell's products do not provide diagnostic conclusions or automated alerts; they are purely tools for data collection. This is particularly important in urgent medical situations, such as Nonconvulsive Status Epilepticus (NCSE), where quick access to brain activity data can significantly impact patient outcomes. Ceribell generates revenue by selling these EEG devices to healthcare providers, adhering to regulations that require a physician's order for their use.

Company Size

201-500

Company Stage

Series C

Total Funding

$146.9M

Headquarters

Mountain View, California

Founded

2014

Simplify Jobs

Simplify's Take

What believers are saying

  • AI integration enhances Ceribell's diagnostic capabilities, providing a competitive market edge.
  • Growing EEG market demand due to rising neurological disorders benefits Ceribell's product sales.
  • Point-of-care testing trend supports adoption of Ceribell's portable EEG system.

What critics are saying

  • Emerging AI-powered EEG technologies increase competition, threatening Ceribell's market share.
  • Regulatory scrutiny on AI medical devices could lead to compliance costs and delays.
  • Scaling production post-IPO may cause supply chain bottlenecks, affecting delivery timelines.

What makes Ceribell unique

  • Ceribell's EEG system is FDA cleared and requires no specialist interpreter.
  • The Brain Stethoscope function converts brainwaves to sound for easy seizure detection.
  • Ceribell's EEG system can be set up in 6 minutes by any healthcare provider.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Unlimited Paid Time Off

Paid Holidays

Parental Leave

Annual Bonus Opportunity

Company Equity

Phone/Internet Stipend

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

-1%

2 year growth

0%
BioSpace
Nov 20th, 2024
Ceribell Appoints Kristie Rodenbush As Chief People Officer And Brian Price As Senior Vice President Of Marketing

—Ms. Rodenbush to lead hiring and talent development initiatives— —Mr. Price to focus on market development and penetration— SUNNYVALE, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions (“Ceribell”), today announced the appointments of Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing to its leadership team. “Ms

Fierce Biotech
Oct 15th, 2024
Ceribell CEO Jane Chao explains why now was the time for its upsized IPO

Ceribell, a former Fierce Medtech Fierce 15 honoree, has been developing a point-of-care electroencephalography platform that combines a disposable, brain-reading headset with artificial intelligence-powered algorithms that help detect hidden seizures-also known as electrographic status epilepticus, or ESE.

Renaissance Capital
Oct 7th, 2024
Seizure diagnostic company CeriBell sets terms for $101 million IPO

CeriBell, a medical device maker with an EEG platform that uses AI to monitor patient seizures, announced terms for its IPO on Monday.

PR Newswire
Apr 2nd, 2024
Ceribell Appoints Sean Manni As Senior Vice President Of Sales

Healthcare sales veteran to lead sales strategies and initiatives to propel continued commercial growthSUNNYVALE, Calif., April 2, 2024 /PRNewswire/ -- Today, Ceribell, Inc.®, the developer of the first AI-powered point-of-care EEG diagnostic system, announced the appointment of Sean Manni as Senior Vice President of Sales. In this role, Mr. Manni will lead Ceribell's commercial sales organization as it continues to expand its U.S. footprint."Sean brings an impressive blend of accomplishments, strategy, and leadership that will undoubtedly elevate our entire commercial organization," said Ceribell co-founder and CEO Jane Chao, Ph.D. "His guidance will be instrumental in developing and executing our plans to further expand our market presence in the U.S., ultimately benefiting patients by increasing access to our groundbreaking technology.""Joining Ceribell represents a unique opportunity to collaborate with an exceptional leadership and sales team," said Manni. "I am deeply committed to leveraging my experience in healthcare sales to further innovate Ceribell's sales strategies and ensure our revolutionary AI-powered point-of-care EEG solutions reach patients in need."Mr

PR Newswire
Jan 4th, 2024
Ceribell To Present At The 42Nd Annual J.P. Morgan Healthcare Conference

SUNNYVALE, Calif., Jan. 4, 2024 /PRNewswire/ -- Ceribell, Inc.®, the developer of the first AI-powered point-of-care EEG system, announced today that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming 42nd Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 8, 2024, at 8:00 a.m. Pacific Standard Time.Event: 42nd Annual J.P. Morgan Healthcare ConferenceDate: Monday, January 8, 2024Time: 8:00 a.m